Who owns Corteria Pharmaceuticals?

Corteria Pharmaceuticals is currently owned by Jeito Capital, through Jeito I, since 2023.

When did Jeito Capital acquire Corteria Pharmaceuticals?

Jeito Capital acquired Corteria Pharmaceuticals in 2023 (active for 3 years).

Home/Companies/Biotech/Corteria Pharmaceuticals

Corteria Pharmaceuticals

Biotech·

France·Active·3yr hold

Corteria Pharmaceuticals is a healthcare company, headquartered in France.

Entry

2023

Hold

3yr

Status

Active

Est. EV

–

Most recent investor

Jeito Capital

2 ownership periods

Key facts

HQFrance

SectorHealthcare

Paris-based clinical-stage biotech developing therapies for heart-failure with preserved ejection fraction; Jeito Capital backed in 2023.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Jeito I

Other portfolio companies in the same fund.

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated April 2026 · Sourced from public filings